LAVA Therapeutics N.V. (LVTX) Financials

$0.96

north_east
$0.03 (2.67%)
Day's range
$0.95
Day's range
$0.97
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning20192019202020202021202120222022202320230%0%-200%-200%-400%-400%-600%-600%-800%-800%Profit Margin
Profit Margin
Revenue
Earnings

LVTX Income statement / Annual

Last year (2023), LAVA Therapeutics N.V.'s total revenue was $6.77 M, a decrease of 65.09% from the previous year. In 2023, LAVA Therapeutics N.V.'s net income was -$41.97 M. See LAVA Therapeutics N.V.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $6.77 M $19.39 M $5.35 M $3.75 M $0.00
Cost of Revenue $3.48 M $0.00 $0.00 $15.70 M $8.35 M
Gross Profit $3.29 M $19.39 M $5.35 M -$11.95 M -$8.35 M
Gross Profit Ratio 0.49 1 1 -3.19 0
Research and Development Expenses $33.81 M $40.11 M $36.95 M $15.70 M $8.35 M
General & Administrative Expenses $12.73 M $14.12 M $12.02 M $2.72 M $1.24 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $12.73 M $14.12 M $12.02 M $2.72 M $1.24 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $46.54 M $51.31 M $46.92 M $3.59 M $1.25 M
Cost And Expenses $50.02 M $51.31 M $46.92 M $19.29 M $9.60 M
Interest Income $2.97 M $257,000.00 $625,000.00 $342,000.00 $86,000.00
Interest Expense $0.00 $0.00 $625,000.00 $342,000.00 $0.00
Depreciation & Amortization $1.28 M $504,000.00 $331,000.00 $213,000.00 $99,000.00
EBITDA -$40.42 M -$30.88 M -$41.02 M -$14.65 M -$9.48 M
EBITDA Ratio -5.97 -1.77 -8.09 -3.86 0
Operating Income Ratio -6.39 -1.8 -8.15 -3.92 0
Total Other Income/Expenses Net $1.56 M $3.18 M $1.42 M -$1.21 M -$104,000.00
Income Before Tax -$41.70 M -$31.66 M -$42.20 M -$15.88 M -$9.69 M
Income Before Tax Ratio -6.16 -1.63 -7.89 -4.24 0
Income Tax Expense $279,000.00 $249,000.00 $157,000.00 $43,000.00 $0.00
Net Income -$41.97 M -$31.91 M -$42.36 M -$15.93 M -$9.69 M
Net Income Ratio -6.2 -1.65 -7.92 -4.25 0
EPS -1.57 -1.23 -2.14 -39.9 -21.65
EPS Diluted -1.57 -1.23 -2.14 -39.9 -21.65
Weighted Average Shares Out $26.73 M $25.92 M $19.76 M $25.35 M $18.41 M
Weighted Average Shares Out Diluted $26.73 M $25.92 M $19.76 M $25.35 M $18.41 M
Link